Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy C Sambol

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmaceutics|August 29, 2024
A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive ImplantLilian W Adeojo, Rena C Patel, Nancy C Sambol
Plos One|May 17, 2016
Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation StudyNancy C Sambol, Jordan W Tappero, Emmanuel Arinaitwe, et al.
Contraception|July 25, 2006
Pharmacokinetics of single-dose levonorgestrel in adolescentsNancy C Sambol, Cynthia C Harper, Lena Kim, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 12, 2008
Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activityMarilyn J Borkgren-Okonek, Robert W Hart, John E Pantano, et al.
The Journal of Infectious Diseases|July 30, 2016
Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated MalariaEskouhie Tchaparian, Nancy C Sambol, Emmanuel Arinaitwe, et al.
Plos Medicine|January 11, 2017
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-AnalysisRichard M Hoglund, Lesley Workman, Michael D Edstein, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmaceutics|August 29, 2024
A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive ImplantLilian W Adeojo, Rena C Patel, Nancy C Sambol
Plos One|May 17, 2016
Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation StudyNancy C Sambol, Jordan W Tappero, Emmanuel Arinaitwe, et al.
Contraception|July 25, 2006
Pharmacokinetics of single-dose levonorgestrel in adolescentsNancy C Sambol, Cynthia C Harper, Lena Kim, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 12, 2008
Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activityMarilyn J Borkgren-Okonek, Robert W Hart, John E Pantano, et al.
The Journal of Infectious Diseases|July 30, 2016
Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated MalariaEskouhie Tchaparian, Nancy C Sambol, Emmanuel Arinaitwe, et al.
Plos Medicine|January 11, 2017
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-AnalysisRichard M Hoglund, Lesley Workman, Michael D Edstein, et al.
Pageof 1